Tanabe Pharma America, Inc.

This study tested the long-term safety of an oral medication called edaravone for people with ALS (amyotrophic lateral sclerosis). The trial followed 185 adults with ALS for 24 to 48 weeks to see how well they tolerated the medication. The goal was to understand potential side ef…

This study tested an investigational drug called MT-7117 to see if it could improve the condition of people with diffuse cutaneous systemic sclerosis, a severe form of scleroderma. For one year, 76 participants with active, early-stage disease received either the drug or a placeb…

This study tested whether an experimental drug called MT-3921 could help improve arm and hand function in people who had recently suffered a severe spinal cord injury in their neck. 72 participants were randomly assigned to receive either the drug or a placebo (inactive substance…

This study aimed to check the long-term safety of an oral medication called edaravone for people with ALS over two years. It was an extension study for 124 participants who had already completed a previous trial. The main goal was to monitor for any side effects or health problem…

This study followed women who had already completed a previous trial to see how safe and effective an investigational drug called MT-8554 was over a longer period. It involved 190 postmenopausal women who experience moderate to severe hot flashes and night sweats. The main goal w…

This study tested whether an experimental drug called MT-8554 could safely reduce the number and intensity of hot flashes in postmenopausal women. For 12 weeks, 375 women with frequent, bothersome hot flashes received either the drug or a placebo pill. Researchers measured how mu…

This study tested an investigational drug called MT-7117 to see if it could help adults with EPP spend more time in sunlight without developing painful skin symptoms. Over 100 participants were randomly assigned to receive either the drug or a placebo for 16 weeks, and researcher…

This study tested whether an investigational drug called MT-7117 could help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP). These conditions cause severe burning, tingling, or stinging pain soon after sunlight exposure. The trial involved 184 par…

This study tested whether an investigational drug called MT-2990 could safely reduce moderate to severe pain in women with surgically diagnosed endometriosis. 76 participants were randomly assigned to receive either the drug or a placebo for 16 weeks to compare pain levels. The m…

This early-stage study aimed to understand how a new drug called MT-8554 is absorbed, processed, and eliminated by the body. Six healthy male volunteers took a single oral dose containing a tiny, safe amount of radioactive tracer to help track the drug. Researchers measured drug …

This early-stage study tested whether an experimental drug called MT-8554 affects the heart's electrical rhythm in healthy adults. Researchers gave 48 healthy volunteers either the drug at two different doses or a placebo (inactive substance) and carefully monitored their heart a…